← All organizations

Dimension Therapeutics

For profit

Also known as: Dimension Therapeutics, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jan 1, 2017

Acquired by Ultragenyx Inc. on Sep 18, 2017

Timeline

2010s

Jun 1, 2013
Dimension Therapeutics— Founded
Sep 18, 2017
Ultragenyx Inc.— Acquired By

Drugs by trial phase (2 distinct, 2 trials)

Phase 2 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (4)

NCT02991144Lead sponsorPhase 1/Phase 2Jan 1, 2017
NCT02991144Study directorPhase 1/Phase 2Jan 1, 2017
NCT02618915Study directorPhase 1/Phase 2Nov 1, 2015
NCT02618915Lead sponsorPhase 1/Phase 2Nov 1, 2015

Details

Founded: Cambridge, MA, US Jun 1, 2013
Last known activity: Jan 1, 2017